Methylation of cytosine to 5-methylcytosine (5mC) is a prevalent DNA modification found in many organisms. Sequential oxidation of 5mC by ten-eleven translocation (TET) dioxygenases results in a cascade of additional epigenetic marks and promotes demethylation of DNA in mammals 1,2 . However, the enzymatic activity and function of TET homologues in other eukaryotes remains largely unexplored. Here we show that the green alga Chlamydomonas reinhardtii contains a 5mC-modifying enzyme (CMD1) that is a TET homologue and catalyses the conjugation of a glyceryl moiety to the methyl group of 5mC through a carbon-carbon bond, resulting in two stereoisomeric nucleobase products. The catalytic activity of CMD1 requires Fe(ii) and the integrity of its binding motif His-XAsp, which is conserved in Fe-dependent dioxygenases 3 . However, unlike previously described TET enzymes, which use 2-oxoglutarate as a co-substrate 4 , CMD1 uses l-ascorbic acid (vitamin C) as an essential co-substrate. Vitamin C donates the glyceryl moiety to 5mC with concurrent formation of glyoxylic acid and CO 2 . The vitamin-C-derived DNA modification is present in the genome of wild-type C. reinhardtii but at a substantially lower level in a CMD1 mutant strain. The fitness of CMD1 mutant cells during exposure to high light levels is reduced. LHCSR3, a gene that is critical for the protection of C. reinhardtii from photo-oxidative damage under high light conditions, is hypermethylated and downregulated in CMD1 mutant cells compared to wild-type cells, causing a reduced capacity for photoprotective non-photochemical quenching. Our study thus identifies a eukaryotic DNA base modification that is catalysed by a divergent TET homologue and unexpectedly derived from vitamin C, and describes its role as a potential epigenetic mark that may counteract DNA methylation in the regulation of photosynthesis.
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Enzymes that target or modify DNA are involved in the epigenetic control of multiple biological processes. In Arabidopsis, 5mC can be targeted directly by specific glycosylases to generate abasic sites 5 . In mammals, 5mC can be oxidized by TET dioxygenases to 5-hydroxymethylcytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine (5caC) [6] [7] [8] [9] . Both of these 5mC-processing mechanisms promote DNA demethylation 2, 10, 11 . Although many other organisms-including the amoeba Naegleria gruberi and the fungus Coprinopsis cinerea-contain 5mC and its oxidative derivatives [12] [13] [14] , other modes of 5mC processing have not been reported 15 .
TET homologues contain a conserved TET-JBP domain that is responsible for enzymatic activity and can be readily identified in a wide variety of organisms, including C. reinhardtii-a unicellular green alga, the lineage of which diverged from land plants more than one billion years ago 16 . The genome of C. reinhardtii contains eight TET homologues 17 (Extended Data Fig. 1 ). These C. reinhardtii (Cr) TET proteins share the conserved His-X-Asp motif for Fe(ii) binding with the dioxygenases from N. gruberi and mammals 12, 18 . However, the binding sites for 2-oxoglutarate (2-OG) appear to be absent in the CrTET proteins, even though 2-OG is an essential co-substrate of all known dioxygenases in this family 19 .
To characterize the CrTET proteins, we performed a dioxygenase activity assay on recombinant proteins purified from Escherichia coli. After incubation of a 5mC-containing DNA substrate with wild-type CrTET1, we detected two unknown products (P1 and P2) in highperformance liquid chromatography (HPLC) analysis at retention times that differed from those of the anticipated nucleosides. These products were not detected with mutant protein controls that lacked His-X-Asp or other conserved motifs (Fig. 1a , Extended Data Fig. 2a-c) . The accumulation of these two products correlated with the reduction of 5mC abundance (Extended Data Fig. 2d , e). Neither 5hmC nor unmodified cytosine could be converted under the same conditions (Extended Data Fig. 2f ). Thin-layer chromatography analysis using 14 C to trace the methyl group in 5mC confirmed that two unidentified nucleotides had been generated and indicated that the methyl carbon had been retained in the products (Fig. 1b) . These observations thus suggested that CrTET1 is a previously undescribed 5-methylcytosine-modifying enzyme, which we named CMD1. Of note, two minor peaks that appeared in the reaction products of wild-type, but not mutant, CMD1 (Fig. 1a, Extended Data Fig. 2f ) represented 5hmC and 5caC (Extended Data Fig. 3a, b) . Thus, CMD1 has an intrinsic capability similar to that of a conventional 5mC dioxygenase, at least in vitro.
To identify the unknown nucleosides P1 and P2, we used highresolution mass spectrometry. P1 yielded an [M+H] + ion at m/z 332.1448 and P2 yielded an ion at 332.1449 (Fig. 2a ) that corresponded to the same molecular formula, C 13 H 22 N 3 O 7 Letter reSeArCH the addition of 90 Daltons (Da) to 5mC ([M+H] + , m/z 242.1134) occurred on the methyl group, we used 5mC-DNA with a fully deuterated methyl group as the substrate (Extended Data Fig. 3c ). Both P1 and P2 showed a 2-Da gain (m/z 334.1569 versus 332.1449; Fig. 2b , Extended Data Fig. 3d ), which indicates that the conversion of 5mC to P1 and P2 generates a new chemical bond to the methyl group of 5mC with concomitant loss of a single deuterium. P1 and P2 have the same collision-induced dissociation fragmentation pattern in tandem mass spectrometry (Extended Data Fig. 3d ), which suggests that they are stereoisomers. After neutral loss of a deoxyribose moiety, three subsequent smaller fragment ions differed in mass by the interval of a water molecule, which suggests that both P1 and P2 contain three hydroxyl groups. These data suggest that the CMD1-catalysed reaction involved the addition of a glyceryl moiety to the methyl group of 5mC.
We determined structures of P1 and P2 using nuclear magnetic resonance (NMR) spectroscopy and density functional theory (DFT) calculation. Cross-peaks in the 1 H-1 H correlation spectroscopy (COSY) and total correlation spectroscopy (TOCSY) spectra (Extended Data Fig. 4a -c) showed that P1 had deoxyribose, cytosine and trihydroxybutyl (THB) moieties, and that cytosine and THB were connected by an oxygen-free CH 2 Table 1 ). We used the J-coupling constants of protons attached to the chiral carbons (C8 and C9) to determine the absolute configurations of these two carbons according to the Karplus equation 20 . Comparison of these J-coupling constants from NMR experiments and DFT calculations (Extended Data Table 1) showed that P1 has an 8S and 9S configuration, and P2 is a stereoisomer of P1 (Extended Data Fig. 5 ) that differs only in the configuration at C8, with an 8R and 9S geometry (Fig. 2c ). P1 and P2 were thus identified as 5-glyceryl-methylcytosines (5gmC).
To identify the origin of the glyceryl group that was transferred to 5mC, we expressed CMD1 in E. coli growing in M9 minimum medium containing 13 C-glucose as the only carbon source. We observed no increase in the m/z of P1 resulting from the use of a 13 C-CMD1 enzyme (Extended Data Fig. 6a ), excluding the possibility that the glyceryl group arose from a component associated with CMD1. Although O 2 was indispensable for the reaction (Extended Data Fig. 6b ), no oxygen atom from either O 2 or H 2 O was incorporated into the P1 nucleoside (Extended Data Fig. 6c ). We therefore searched for a glyceryl-containing component in the reaction buffer that was necessary for the 5mC modification. We found that the reaction was completely dependent on the presence of vitamin C and Fe
2+
, but not 2-OG (Fig. 3a , Extended Data Fig. 6d, e) . Vitamin C typically acts as an enhancing factor to facilitate the stabilization of Fe 2+ and is non-essential for previously characterized dioxygenases, such as human TET2 7 (Extended Data  Fig. 6f ). The substitution of vitamin C with its analogues or derivatives did not support the activity of CMD1 (Extended Data Fig. 6g-i) . The replacement of unlabelled vitamin C with uniformly 13 C-labelled vitamin C ( 13 C 6 -VC) increased the mass of the P1 nucleoside by 3 Da, which suggests that vitamin C is the donor of the 3-carbon unit for 5mC alkylation (Fig. 3b) . Furthermore, the use of selectively 13 C-labelled vitamin C showed that C4-C6 of vitamin C were incorporated into the P1 nucleoside (Extended Data Fig. 7a, b) . Thus, vitamin C specifically contributes to glycerylation as an essential co-substrate in CMD1-mediated 5mC modification.
Because CMD1 requires both Fe 2+ and its binding motif His-X-Asp, but has distinct co-substrate requirements (Fig. 3a, b , Extended Data Fig. 6d-i) , we propose that CMD1 uses a reaction mechanism similar to that of 5mC oxidation catalysed by Fe(ii)-and 2-OG-dependent TET dioxygenases 3, 12 . CMD1 uses vitamin C in the place of 2-OG, and O 2 for coordination with ferrous iron, yielding an Fe(iv)=O intermediate through oxidative decarboxylation of vitamin C (Extended Data Fig. 7c ). This intermediate is reactive and may abstract a hydrogen atom from 5mC to initiate C-C bond cleavage of coordinated l-xylonic acid and attack of the resulting 5mC radical, which leads to the production of 5gmC nucleotides in DNA and glyoxylate as a co-product. This mechanism is consistent with the mixed stereochemistry observed at C8 in P1 and P2. To confirm this hypothesis, we used gas chromatography-mass spectrometry (GC-MS) to detect CO 2 . In the presence of 13 C 6 -VC, 13 C-labelled CO 2 (molecular mass 45.0) was produced, and the use of selectively 13 C-labelled vitamin C confirmed that CO 2 was derived from C1 of vitamin C (Extended Data Fig. 7d ). Furthermore, glyoxylic acid was also identified by liquid chromatography-mass spectrometry (LC-MS) analysis after derivatization with 2,4-dinitrophenylhydrazine (DNP), thus clarifying the fate of the remaining carbons C2 and C3 of vitamin C (Extended Data Fig. 7e) . Therefore, CMD1 appears to be a vitamin-C-dependent oxygenase that catalyses the reaction that leads to transfer of the Letter reSeArCH glyceryl portion of vitamin C to 5mC, thereby producing 5gmC in DNA along with CO 2 and glyoxylic acid as co-products (Fig. 3c) .
We detected 5gmC unambiguously in vivo at a level of about 10 per million cytosines, or 0.25% of 5mC, in the genomic DNA of wild-type C. reinhardtii (Fig. 4a) . To verify that 5gmC is generated by CMD1, we generated a CMD1 mutant (hereafter cmd1) strain using the CRISPRCas9 system (Extended Data Fig. 8a-f) . The cmd1 strain contained about 60% less 5gmC and twice as much 5mC as did wild-type cells (Fig. 4a) . To investigate whether vitamin C is the glyceryl donor for 5gmC formation in vivo, we generated vitamin-C-deficient strains (vtc2) by knocking out the key vitamin-C synthesis gene VTC2 21 (Extended Data Fig. 9a ). In vtc2 mutant strains, vitamin C content was reduced to about 10% of the wild-type level (Extended Data Fig. 9b ). Consequently, vtc2 mutant cells contained about 80% less 5gmC and twice as much 5mC as did wild-type cells (Fig. 4a) . When wild-type C. reinhardtii was grown in the presence of the DNA methyltransferase inhibitor 5-azacytidine, the 5mC level was reduced by over 50%. As a consequence, the 5gmC level was decreased by 13% (Extended Data  Fig. 10a ). These data support the idea that 5gmC is derived from vitamin C and 5mC in vivo.
Despite the marked alteration in genomic 5gmC and 5mC levels, the cmd1 strain did not exhibit noticeable morphological and growth phenotypes under low light. However, when cultured photo-autotrophically under high light, cmd1 cells were more prone than wild-type cells to light-induced damage (Fig. 4b) . This phenotype co-segregated with the CMD1 mutation following mating and tetrad dissection (Extended Data Fig. 8g ). Non-photochemical quenching (NPQ) is a photoprotective process that promotes fitness under high light and requires LHCSR3 (light-harvesting complex stress-related protein 3) 22 . Complete knockout of LHCSR3 (npq4) resulted in a severe impairment of NPQ (Fig. 4c) . In cmd1 cells, NPQ induction under high light was similarly compromised (Fig. 4c) . In addition, the photosynthetic electron transport rate was also reduced during high light flux in cmd1 cells (Extended Data Fig. 10b ). This suggests that the increased sensitivity to excess light could be due to an overall reduction in photosynthetic capacity. RNA sequencing (RNA-seq) revealed that more than 20 photosynthesis-related genes showed alterations in expression in cmd1 cells, including a reduction in transcripts of LHCSR3 (Extended Data Fig. 10c-e) . In addition, both protein and mRNA expression of LHCSR3 were lower in the cmd1 mutant strain than in the wild-type after exposure to high light (Fig. 4d, e) .
To investigate the link between altered gene expression and localized changes in 5mC, we performed whole-genome bisulfite sequencing on both wild-type and cmd1 strains. In the wild-type strain, genes that were expressed at lower levels tended to be more methylated, and Fig. 3 | Vitamin C is required as a glyceryl donor in CMD1-catalysed modification of 5mC. a, Dependence of CMD1 activity on vitamin C (VC) to modify 5mC. Reactions were performed under indicated conditions for HPLC detection of P1 and P2 nucleosides. Data are representative of at least three independent experiments. The y axis shown applies to all four traces. b, Isotope tracing of P1 nucleoside using 13 C-labelled vitamin C. Reactions were performed using 12 C-or 13 C-vitamin C and molecular masses of P1 nucleosides were measured using mass spectrometry. Data are representative of two independent experiments. c, CMD1-catalysed modification of 5mC in the presence of vitamin C and O 2 . As a co-substrate in the reaction, vitamin C provides a glyceryl moiety (red), which is transferred onto the methyl group of 5mC to produce the P1 and P2 forms of 5gmC nucleotides in DNA. The wavy line linking a hydroxyl group to C8 in the base product denotes the presence of the two configurations identified for the stereoisomers P1 and P2 (Fig. 2c) . Letter reSeArCH genes that gained promoter methylation in the cmd1 strain tended to be downregulated compared to the wild-type (Extended Data Fig. 10f-k) . This indicates that DNA methylation and gene expression are inversely correlated in C. reinhardtii. Bisulfite sequencing confirmed that the analysed region 5′ of LHCSR3 in cmd1 cells was hypermethylated ( Fig. 4f , Extended Data Fig. 10l ), which may have led to the impaired expression of LHCSR3 in cmd1 cells. Consistently, vtc2 cells also showed increased methylation and reduced expression of LHCSR3, as well as compromised induction of NPQ (Extended Data Fig. 9c-e) . On the other hand, VTC2 expression and vitamin C content were higher in cmd1 cells than in wild-type cells (Extended Data Fig. 9b, f) . This implies both the existence of a compensatory mechanism and a functional connection between vitamin C content and NPQ capacity regulated by CMD1.
To confirm that CMD1 function is required for the regulation of photo-acclimation, we carried out complementation experiments. Constitutive expression of wild-type CMD1-but not the catalytically inactive mutant-in cmd1 cells restored hypomethylation and expression of LHCSR3, together with NPQ-mediated photoprotection ( The increase in 5mC in cmd1 cells, both globally and at the 5′ region of LHCSR3 (Fig. 4a, f) , suggested that CMD1 may counteract cytosine methylation in suppressing transcription, reminiscent of the role of TET dioxygenases in antagonizing DNA methyltransferases in mammals 23 . However, the biological relevance of cytosine methylation in C. reinhardtii has been under-investigated and, unlike in other organisms, no correlation between 5mC deposition and gene expression has been established 24 . To test the effects of 5mC and 5gmC on gene expression, we introduced these two modifications into two luciferase reporter plasmids in vitro before transformation into C. reinhardtii. Whereas 5mC alone strongly and stably repressed transcription of the reporter, its conversion to 5gmC substantially alleviated this repression in a time-dependent manner (Extended Data Fig. 11e ); this effect was correlated with the de-modification of 5gmC to cytosine (by 13.4% at 48 h), as revealed by 5gmC mapping experiments (Extended Data Fig. 11f-h ). These observations indicate that 5gmC can promote demethylation and thus increase gene expression. Of note, the relevance of 5gmC in the control of target genes in vivo was also supported by chromatin immunoprecipitation (ChIP) data showing that CMD1 was enriched at the 5′ region of LHCSR3 (Extended Data Fig. 11i ).
We have shown that 5mC in the C. reinhardtii genome can be further modified by the addition of a glyceryl group from vitamin C to form 5gmC, a nucleobase generated by the TET homologue CMD1. Vitamin C is widely believed to function as an antioxidant and promotes the recycling of Fe 2+ in numerous contexts, including the epigenetic reprogramming of cell fates by TET enzymes and histone demethylases 25, 26 . Our observation that vitamin C acts as an essential co-substrate raises the possibility that vitamin C might have a more direct role in epigenetic regulation. Functionally, our data implicate CMD1-catalysed glycerylation of 5mC in the control of the transcriptional competence of LHCSR3, a gene that is critical for the acclimation of algal cells to excess light 22, 27 . This observation adds an additional layer of complexity to the regulation of photoprotection by LHCSR3, which is induced by a blue-light-sensing photoreceptor 28 . Our data suggest that suppression of transcription by 5mC might be conserved in C. reinhardtii. Although 5gmC itself appears to negatively affect transcription, it can promote demethylation and thus de-repression over time. Among other possibilities, the demethylation process triggered by 5gmC could take place either through passive dilution owing to inhibition of maintenance methylation or through base excision repair by a specific glycosylase capable of excising 5gmC. The C. reinhardtii genome contains homologues of TDG and AlkD glycosylases, which can excise 5caC and bulky base modifications, respectively 6, 29 . Further understanding of the roles of and interactions between the two cytosine modifications in the C. reinhardtii genome requires the generation and analysis of mutants that completely lack 5gmC. In principle, 5gmC can function as an independent epigenetic mark, similar to 5mC and N 6 -methyladenine marks in various organisms 30 . Finally, given its selectivity, modification of 5gmC by CMD1 might be useful for DNA technologies such as the genome-wide mapping of 5mC.
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Letter reSeArCH 29. Mullins, E. A. et al. The DNA glycosylase AlkD uses a non-base-flipping mechanism to excise bulky lesions. Nature 527, 254-258 (2015 18 and the construct was transformed into E. coli strain BL21 (DE3). The CMD1 mutants were constructed in the same vector. The bacterial cells were grown to an absorbance of 0.8 at OD 600 and induced with 0.1 mM isopropyl-β-d-thiogalactopyranoside (IPTG) at 16 °C for 16 h. Tagged CMD1 protein was bound to Ni-NTA beads (Qiagen) and cleaved from the His-SUMO tag by overnight incubation with His-tagged Ulp1 protease at 4 °C. The collected CMD1 protein was further purified using a Resource Q anion exchange column (GE Healthcare) with a linear gradient of buffer A (20 mM Tris-HCl, pH 8.5)/buffer B (20 mM Tris-HCl, pH 8.5, 1 M NaCl) from 100/0 to 50/50, and a Superdex 200 10/300 GL gel filtration column (GE Healthcare) in buffer (20 mM HEPES pH 7.0, 100 mM NaCl). The protein was concentrated to 10 μg/μl using Ultracel-10K centrifugal filters (Millipore). Preparation of DNA substrates for CMD1 reaction in vitro. A 1.1-kb 5mC-containing DNA fragment (5mC-DNA) was prepared by PCR amplification from a randomly selected portion of C. reinhardtii genomic DNA using 5-methyl-dCTP. We also used 5-hydroxymethyl-dCTP and unmodified dCTP in PCR to prepare 5hmC-DNA and C-DNA, to test the substrate specificity of CMD1. The forward primer used was 5′-biotin-AAGGGTTGGATTGTAGGTAGTTTAGAAAT-3′ and the reverse primer was 5′-TGAGGGTGGTAAATTAG-3′. Dioxygenase assay. Typically, 0.5 μg of biotinylated 5mC-DNA was incubated with 4 μg CMD1 or human (h) TET2 enzyme (at about 1:2 molar ratio of enzyme to 5mC) in a total volume of 100 μl at 37 °C for 1 h in the presence of 50 mM HEPES (pH 7.0 for CMD1, pH 8.2 for hTET2), 50 mM NaCl, 1 mM l-ascorbic acid, 1 mM 2-OG, 0.1 mM Fe(NH 4 ) 2 (SO 4 ) 2 , 1 mM DTT and 1 mM ATP as previously described 6 . For the 13 C-tracing experiment, 13 C-labelled l-ascorbic acid (Omicron Biochemicals) was used in the reaction. After treatment with proteinase K (Lifefeng, RE111-03), the DNA was purified using streptavidin sepharose beads (GE Healthcare) according to the manufacturer's instructions. HPLC analysis of nucleoside hydrolysates of CMD1-modified DNA. HPLC analysis was performed as previously described 6 . In brief, purified biotinylated DNA was digested by nuclease P1 (Sigma) in the presence of 0.2 mM ZnSO 4 and 20 mM NaAc (pH 5.3) at 55 °C for at least 1 h and then was dephosphorylated with calf intestinal alkaline phosphatase (CIAP, Takara) at 37 °C for an additional 1 h. The samples were centrifuged and the supernatants were analysed using an Agilent 1260 HPLC with a Welch AQ-C18 column (4.6 × 250 mm, 5 μm) at 15 °C. The mobile phase was 10 mM KH 2 PO 4 (pH 3.95), running at 0.6 ml/min or 20 mM NH 4 Ac (pH 5.21), running at 1 ml/min, and the detector was set to 280 nm. The DNA was purified using Qiaquick Nucleotide Removal Kit (Qiagen) and used for CMD1 reaction. Analysis of 5mC derivatives using thin-layer chromatography. In brief, after incubation of 14 C-5mC-DNA with CMD1, the samples were treated with proteinase K and purified by phenol-chloroform extraction and ethanol precipitation before being dissolved in 8 μl water. The DNA was digested using nuclease P1 and then 0.5 μl of the digestion product was spotted onto a PEI-cellulose thinlayer chromatography plate (Merck). The plate was developed in isopropanol:HCl:H 2 O (70:15:15) and then analysed by phosphorimager scanning with FujiFilm Fluorescent Image Analyzer FLA-3000. LC-MS analysis. To determine the molecular mass of the new products of 5mC generated in the CMD1-catalysed reaction, we collected nucleoside fractions of interest from HPLC and subjected them to mass spectrometry analysis. Ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) was performed using a Q Exactive (Thermo Scientific) mass spectrometer in positive-ion mode with an ACQUITY UPLC HSS T3 (1.8 μm, 2.1 mm × 100 mm, Waters) column. Buffers A (water containing 0.05% CH 3 COOH) and B (acetonitrile, ACN) were used as mobile phase at a flow rate of 0.3 ml/min. The gradient began with a condition of 100% A, followed by a linear gradient of 95% A at 2 min, 50% A at 4 min, which was held for 1 min, followed by 0% A at 5.1 min, then re-equilibrated to the starting condition at 8 min, holding for 1 min.
For glyoxylic acid analysis, the reaction mixture was filtered after the reaction to remove proteins and precipitates. Derivation was carried out using 2,4-dinitrophenylhydrazine (DNP) as previously described 31 before LC-MS analysis. The LC-MS program was identical to that used for nucleoside analysis.
For quantitative determination of the content of 5gmC nucleosides in genomic DNA, multiple reaction monitoring (MRM)-based liquid chromatographytandem mass spectrometry (LC-MS/MS) analysis was used. The LC-MS/MS analyses were performed using a UPLC system (1290 series, Agilent Technologies) coupled to a triple quadrupole mass spectrometer (Agilent 6495 QQQ, Agilent Technologies). An ACQUITY UPLC BEH amide column (1.7 μm; 2.1 mm × 100 mm, Waters) was used for the liquid chromatography separation. The mobile phases (A, 25 mM ammonium acetate and 25 mM ammonium hydroxide in 100% water; B, 100% acetonitrile) were used for compound separation. The linear gradient elutes from 85 to 40% B (0-2 min), 40% B (2-4 min), 40 to 85% B (4-4.1 min), then stays at 85% B until 7 min for re-equilibrium. The flow rate was set to 0.6 ml/min. Optimized MRM transition parameters for each of the nucleosides 5gmC, 5mC and C, G were obtained using pure compound standards. 5gmC: 332. 1 
GC-MS analysis.
For the analysis of CO 2 , the CMD1-catalysed reaction was performed in sealed vials under N 2 atmosphere in a glove box, with pure O 2 air blown manually. The reaction products within the vials were directly subjected to GC-MS analysis using an Agilent 7890A GC, equipped with an Agilent J&W GC 113-3133 column (30 m × 320 μm × 3 μm) and a mass spectrometer 5975C as the detector. Helium was used as the carrier gas, at a flow rate of 1.5 ml/min. Oven temperature was initially 35 °C for 6 min, then gradually increased to 320 °C at 11 min. Determination of cellular content of vitamin C. The method for vitamin C content quantification was based on a published protocol 32 , but with some modifications. The algal cells were cultured in TAP medium to mid-exponential phase. Cells (1 × 10 7 ) were collected in a 1.5-ml centrifuge tube and washed with 1 ml water. The cell pellet was frozen in liquid nitrogen. Vitamin C was extracted by adding 300 μl extraction buffer (2 mM EDTA, 10 mM DTT) followed by vigorous shaking. Glass beads (100 μl, Sigma) were added and vortexed using a bead-beater at maximum speed for 30 s. The samples were centrifuged at 19,000g at 4 °C for 30 min. The supernatant was collected and filtered into chromatographic vials using 4-mm hydrophilic PTFE syringe filters with a pore size of 0.22 μm (Microlab).
Vitamin C was quantified using LC-MS. It was separated chromatographically using a Q Exactive LC-MS system (Thermo Scientific) with an ACQUITY UPLC BEH Amide Column (130Å, 1.7 μm, 2.1 mm × 50 mm, Waters) with negative ion mode. The tray temperature of the autosampler was set at 4 °C and the column oven temperature at 30 °C. For the elution of vitamin C, the flow rate was set at 0.3 ml/min, and the mobile phase used was A = 25 mM NH 4 Ac + 25 mM NH 3 ·H 2 O, B = ACN. The linear gradient eluted from 95% B for 2 min, 95% B to 40% B (2-6 min), then stayed at 40% B until 9 min for re-equilibrium. The amount of vitamin C was calculated according to the calibration curve. The cellular vitamin C concentration was calculated using the following formula 33 and their NMR data were acquired on Bruker 600 MHz and 850 MHz spectrometers, both equipped with 5-mm cryogenic TCI probes. One-dimensional 1 H NMR spectra and a set of 2D NMR spectra were recorded and processed as previously reported 34 
-H ) were calculated for those protons attached to the chiral carbons (C8 and C9) and their adjacent carbons (C7 and C10). For both nucleosides P1 and P2, such constants were calculated for all four possible configurations (that is, 8R, 9R; 8S, 9S; 8R, 9S; 8S, 9R) using the DFT approach after molecular geometries were fully optimized at the wb97x-d/6-311G (d,p) level. All calculations were carried out using the Gaussian 09
Letter reSeArCH software package with the Fermi contact, diamagnetic spin-orbit, paramagnetic spin-orbit and spin-dipole terms being taken into consideration according to the Ramsey theory 36 . C. reinhardtii strains and culture conditions. Wild-type strains (CC124 and CC125) were obtained from the C. reinhardtii Resource Center. The npq4 mutant strain 22 For 5-aza-2′-deoxycytidine (5-aza, Sigma) treatment, CC125 cells at a cell density of 1.2 × 10 4 ml -1 were cultured in TAP medium in the presence of 400 μM 5-aza. On day 2 the medium was changed to TAP medium with fresh 400 μM 5-aza, and the cells were collected on day 4 for further analysis. Gene editing in C. reinhardtii based on CRISPR-Cas9-mediated co-selection. The principle and flow chart of the gene-editing procedure are summarized in Extended Data Fig. 8a, b . In brief, a pPEI-His-SUMO-SpCas9 plasmid was transformed into E. coli strain Transetta (DE3) (TransGen Biotech). SpCas9 protein was bound to Ni-NTA beads and collected from the resin in elution buffer (20 mM HEPES, pH 7.5, 150 mM KCl, 1 mM DTT, and 10% glycerol). The eluted sample was next loaded into a 5-ml HiTrap SP HP Sepharose column (GE Healthcare Life Sciences) and eluted with buffer A (20 mM HEPES pH 7.5, 1 mM DTT and 10% glycerol) with a linear gradient of 100 mM to 1 M KCl. The fractions containing SpCas9 were mixed and concentrated to 500 μl with a centrifugal filter (30 kDa, Millipore) and further purification was performed by gel filtration on a Superdex 200 16/300 column (GE Healthcare Life Sciences) in GF buffer (20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT and 10% glycerol). The eluted SpCas9 sample was then filtered through a 0.2-μm Whatman filter to remove possible bacterial contamination.
The single guide RNAs (sgRNAs) in C. reinhardtii were designed using CRISPR RGEN Tools (http://www.rgenome.net/cas-designer/). The sgRNA was prepared in vitro using the MEGAshortscript T7 kit (Ambion). The sgRNA sequences are: MAA7: CAUAGCGACCAUUUGCGUCC; CMD1: GGAACAUCU CGUCGCAUGCU; VTC2: UUUCCCGGCUACUGGCGUUU. Genotyping primers are as follows: MAA7-F: GCGTAATTCGGCTACTTTCAC; MAA7-R: TCTCAGCAAACACCCGTCAT T; CMD1-primer1-F: TGCTATG GGCGTCTCGCTCAC; CMD1-primer2-F: CGTTTAACGACTGGAAGGCTGC; CMD1-primer1/2-R: TCGGCATGGATAGATGGTCAGAC; CMD1-primer3-F: GCAAAATGAGTGTCGCCCTA; CMD1-primer3-R: TAGAAAACCACCTCCTGCCC; VTC2-F: GGAGCTTTTCGTCGATCAACA; VTC2-R: CGTCTGTCACTGCAACTACG.
For the transformation experiment, C. reinhardtii cells (CC125, mt+) were grown to a cell density of 2 × 10 6 cells ml -1 in TAP medium. For electroporation, 2 × 10 7 cells were suspended in 1 ml Max Efficiency Transformation Reagent (Thermo Fisher Scientific), followed by suspension in the same reagent supplemented with 60 mM sorbitol. Purified SpCas9 (100 μg, 0.53 nmol) in storage buffer (20 mM HEPES pH 7.5, 150 mM KCl, 1 mM DTT, and 10% glycerol) was preincubated with the sgRNA for MAA7 and the sgRNA for the CMD1 gene (0.8 nmol each) at a 1:1.5:1.5 molar ratio at 37 °C for 15 min to assemble ribonucleoprotein (RNP) complexes. For co-transformation of C. reinhardtii, 250 μl of cell suspension (5 × 10 6 cells) was mixed with the preincubated RNP complexes. Cells were electroporated in a 4 mm cuvette (600 V, 50 μF, infinite resistance) using Gene Pulser Xcell (Bio-Rad) as described 38 . Immediately after electroporation, 600 μl TAP with 60 mM sorbitol was added. Cells were recovered overnight in 10 ml TAP with 60 mM sorbitol shaken at 110 r.p.m. under continuous low light and then plated onto TAP medium supplemented with 25 μM 5-fluoroindole (5-FI) and 20% starch. The plates were incubated under 30 μmol photons m -2 s -1
. The 5-FI resistance colonies appeared after 5-7 days and were picked up for genotype characterization. Backcross and random spore analysis. The selected cmd1 mutant clone was backcrossed with wild-type CC124 (mt-) to segregate the MAA7 mutation from other potential off-target genetic alterations. For gametogenesis, 20 ml of each type of vegetative cells was cultured to a concentration of 2 × 10 6 ml -1
. The cells were resuspended and cultured in M1 medium depleted of nitrogen under a light intensity of 120 μmol photons m -2 s -1 for 18 h. Gametes were mixed in the dark for 2 h then 0.2 ml of the mixed cultures were spread onto a 4% agar TAP plate and exposed to light for 1 d and then stored at darkness for 5 d for maturation of zygotes. All the cells were collected and treated with 2% SDS for 2 h at room temperature. Subsequently, the cells were washed with TAP medium at least six times before being plated onto a TAP plate. After zygote germination, the cells were diluted and plated onto a TAP plate again to isolate single clones for genotyping. Multiple independent cmd1 clones obtained from two consecutive crosses were used for phenotype characterization.
For the random spore analysis, gametes on 4% agar plates were removed with a razor blade (the zygotes stick to the agar plate) and the remaining gametes were killed with chloroform. About 30 zygotes on a small piece of agar were transferred to the germination plate (1% TAP agar plate) and incubated under the light for 20 h. Then 0.1 ml TAP medium was added to the agar to release the daughter cells from the zygotes, and then the medium was spread onto the whole plate. After 5-8 days, meiotic products grew into visible colonies that were picked for subsequent analysis. The colonies were grown in 1 ml TAP medium in 24-well plates at low light for 2 days, and then diluted to OD 620 = 0.1 with TAP medium. Cells (3 μl) were spotted onto 1.5% agar plates and the plates were incubated in low light (20 ) for 66 h. Gene complementation in C. reinhardtii. For the complemented expression of wild-type or mutant CMD1 in the cmd1 strain, the Hsp70A/Rbcs2 (HSRB) fusion promoter and PsaD terminator were used. An HA-tag coding sequence was fused at the C terminus-coding sequence of a cloned CMD1 genomic fragment. The paromomycin resistance gene AphVIII was fused downstream as a selection marker. For the expression of LHCSR3, the Hsp70A/Rbcs2 fusion promoter and PsaD terminator were added to the full-length genomic LHCSR3.1 gene. In this construct, the AphVIII marker driven by Hsp70A/Rbcs2 fusion promoter was included. The constructs were introduced into cmd1 cells by electroporation using BTX Gemini SC2 Electroporation System in a 4-mm cuvette (600 V, 50 μF, infinite resistance). The transformants were screened for their resistance to 10 μg ml −1 paromomycin and identified by western blot analysis with anti-HA (Cell Signaling Technology) and anti-LHCSR3 (Agrisera) antibodies. RNA preparation and gene-specific mRNA quantification. Total RNA was extracted from C. reinhardtii using Trizol (Thermo) according to the instruction manual. To measure gene expression, quantitative RT-PCR was performed using CFXP6 Real-Time PCR with SYBR Premix Ex Taq (Tli RNaseH Plus, Takara). A gene encoding G-protein-subunit-like protein (GBLP) was used as the endogenous control.
The primers used were:
GBLP-qRT-F (5 ʹ-CAAGTACACCATTGGCGAGC-3ʹ) and GBLP-qRT-R (5ʹ-CTTGCAGTTGGTCAGGTTCC-3ʹ).
Western blot analysis. Cells were collected by centrifugation at 12,000g for 30 s, and resuspended in 60 μl SBA buffer (100 mM DTT, 100 mM Na 2 CO 3 ) with 40 μl SBB buffer (30% sucrose, 5% SDS). The samples were vortexed for 20 min at room temperature and then subjected to three freeze-thaw cycles. After centrifugation, the supernatants were loaded onto a 10-12.5% SDS-PAGE gel and the proteins were blotted onto a nitrocellulose membrane. Membranes were blocked for 0.5 h with 5% milk in TBST and then incubated with anti-LHCSR3 polyclonal antibody (Agrisera) diluted 1:10,000 in TBST or anti-HA monoclonal antibody (Cell Signaling Technology), diluted 1:1,000 or anti-α-Tubulin monoclonal antibody (Sigma) diluted 1:1,000 for 1 h and then rinsed 3 times for 5 min before incubation with peroxidase-conjugated affinipure goat anti-rabbit IgG (Jackson) or peroxidase-conjugated affinipure goat anti-mouse IgG (Jackson), both diluted 1:10,000 for 1 h. The blots were developed with ECL detection reagent (Millipore) and images of the blots were obtained using a CCD imager (Thermo). Large-scale DNA preparation from C. reinhardtii. Total DNA was isolated using CTAB method as described 39 and was dissolved in nuclease-free water for further analysis. Southern blotting of genomic DNA. Total DNA (10 μg) was digested using SalI and NheI restriction enzymes and samples were separated by electrophoresis on a 1% agarose gel. After treating the gel in 0.2 N HCl for 10 min, denaturation buffer (1.5 M NaCl, 0.5 M NaOH) for 30 min, and neutralization solution (0.5 M TrisHCl, 3 M NaCl, pH 6.8) for 30 min, the DNA in the gel was blotted onto nylon membrane by capillary transfer in 20× SSC buffer. The Southern blotting probe fragment was prepared by PCR amplification from the C. reinhardtii genomic DNA using primers: CMD1-Southern-F (5ʹ-GGCCAAACAACCGAGTCTTG-3ʹ) and CMD1-Southern-R (5ʹ-CACAGCAACAACACCACTCA-3ʹ). Probe labelling and the detection of hybridization signal were performed using the DIG High Prime Labelling and Detection Starter Kit II (Roche) according to the instruction manual.
Bisulfite sequencing (BS-seq) and TET bisulfite sequencing (TET BS-seq).
For bisulfite sequencing, genomic DNA was extracted and treated with the EZ DNA Methylation-Direct Kit (Zymo Research). The bisulfite-treated DNA was subjected to PCR amplification using Taq HS polymerase (TAKARA). The bisulfite primers were LHCSR3-BSF (5ʹ-TGGGTTGGTTGATATAGTTTGATA-3ʹ), and
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LHCSR3-BSR (5ʹ-AATCTCRCTAACTCCCCTATCT-3ʹ); HSRB-BSF (5ʹ-TGAAGT TATAGGATTGATTTGG-3ʹ), and HSRB-BSR (5ʹ-TACAAATACTCAAATACCC CAT-3ʹ)
. PCR products were then purified with a Gel Extraction Kit (Qiagen) and cloned into a pClone007 Simple Vector (Tsingke). Individual clones were sequenced by standard Sanger sequencing. Data were analysed using the online tool QUMA (http://quma.cdb.riken.jp/).
For TET BS-seq, genomic DNA was subjected to oxidation by recombinant human TET2CD before bisulfite treatment. In brief, 200 ng DNA was incubated with 10 μg hTET2CD in a total volume of 20 μl at 37 °C for 3 h in the presence of 50 mM HEPES (pH 8.2), 50 mM NaCl, 1 mM l-ascorbic acid, 1 mM 2-OG, 0.1 mM Fe(NH 4 ) 2 (SO 4 ) 2 , 1 mM DTT and 1 mM ATP. After that, TET-treated DNA was directly used for BS-seq as described above. Chlorophyll fluorescence measurements. Chlorophyll fluorescence of C. reinhardtii cells was measured using a Dual-PAM-100 (Walz) with an emitter-detector unit ED-101US/MD. Wild-type and cmd1 strains were cultured under 180 μmol photons m -2 s -1
. Cells were then exposed to actinic light of 600 μmol photons m ), in which F s is the steady-state fluorescence level. Luciferase assay. For the construction of the luciferase reporter, we fused the Hsp70A/Rbcs2 fusion promoter and PsaD terminator with the renilla coding sequence. Independently, the promoter region of LHCSR3. 1 (chromosome_8: 1945381-1947449 ) was cloned to generate another reporter plasmid. The plasmids were treated with M.SssI methyltransferase (Zymo Research) to generate 5mC-plasmids. 5mC-plasmids were further treated with CMD1 to generate 5gmC-plasmids. For luciferase assay, these plasmids were linearized and introduced into wild-type CC125 cells by electroporation with BTX Gemini SC2 Electroporator in a 4-mm cuvette (600 V, 50 μF, infinite resistance). The cells were collected at different times and subjected to luciferase activity measurement with Renilla Luciferase Assay System (Promega). The luciferase activity was normalized to the corresponding chlorophyll fluorescence and then compared to the value of the mock control, which was set to 1. Each experiment was repeated three times. Chromatin immunoprecipitation (ChIP) assay. The ChIP assay was performed as described 40 . An anti-HA monoclonal antibody (Cell Signaling Technology) was used to pull down CMD1-HA, with mouse IgG used as a negative control. The pulldown complex was eluted and subjected to quantitative RT-PCR. Signals for individual genomic regions from anti-HA pulldown samples were normalized against IgG control samples and then to the corresponding signals of cmd1 cells lacking CMD1-HA, which was set to 1. Primers used were as follows: F1: 5ʹ-TGTGT TTCCGACTTTGCCAG-3ʹ, R1: 5ʹ-GACACGACATCACACGACAG-3ʹ; F2: 5ʹ-CACTCCTCCCTCTCCTTGC-3ʹ, R2: 5ʹ-GAAGAAGAGGCGGTGGAGAG-3ʹ; F3: 5ʹ-GGTTGCAACACCCTAACGTT-3ʹ, R3: 5ʹ-CCCATGAAACCAAGCACC AA-3ʹ; F4: 5ʹ-CATACGGGGTCCCTACACTC-3ʹ, R4: 5ʹ-TGTCCAGTGAGAAGT AGCCG-3ʹ. Statistical analysis. No statistical methods were used to predetermine sample size, the experiments were not randomized and the investigators were not blinded to allocation during experiments and outcome assessment. All values are expressed as mean ± s.e.m. and calculated from the average of at least two independent biological replicates. The statistical significance of differences was estimated by Student's t-tests, using GraphPad software. P < 0.05 was considered significant. All other statistical tests are described in the figure legends and Methods. Whole-genome bisulfite sequencing. Genomic DNA was isolated as described above. For library preparation, genomic DNA spiked with unmethylated lambda DNA (~2% of the genomic DNA) was sheared by Covaris S220 to generate fragments (~300 bp in length). Then about 500 ng of sheared DNA was converted by bisulfite and purified with EZ DNA Methylation-Direct Kit (Zymo Research). DNA libraries were prepared using TruSeq DNA Methylation Kit (Illumina) and sequenced on Illunima NextSeq-500 platform with pair-end 150 bp mode. After quality control (FastQC Version 0.11.5) and adaptor trimming (Trimmomatic 41 V0.36), the clean reads were aligned to the C. reinhardtii genome (V5.5, Phytozome) using BSMAP version v2.9 42 . Raw methylation estimates were called for cytosines covered by at least twenty reads. Commonly detected cytosine sites were averaged across replicates to increase robustness. To determine the methylation status of genes, methylation ratios of cytosines within the promoter region (2 kb upstream of transcription start site (TSS)) were collected and compared between wild-type and CMD1 mutant samples using the Wilcoxon signed-rank test and corrected for false discovery rate (FDR) by the Benjamini-Hochberg method 43 . Fold changes, absolute differences and percentages of relative differences were also calculated. To control for false positives more stringently, we identified differentially methylated genes as those with FDR values below 0.001 combined with a 20% relative change and an absolute methylation change of 0.04 in the methylation level. Functional enrichment was analysed using Gene Ontology annotation and Fisher's exact test. RNA-seq analysis. Total RNA was extracted from C. reinhardtii using Trizol (Thermo). RNA libraries were prepared using TruSeq Stranded Total RNA Sample Prep Kit (Illumina) and sequenced using Illumina Hiseq Xten platform with pairend 150-bp mode. After quality control (FastQC Version 0.11.5) and adaptor trimming (Trimmomatic 41 V0.36), the clean reads were aligned to the C. reinhardtii genome (V5.5, Phytozome) using TopHat2 (version v2.1.1) 44 with default settings. The transcription levels of annotated genes (fragments per kilobase of transcript per million mapped reads) were quantified and normalized using Cufflinks (v2.0.0) 45 with default parameters. Differential analysis was performed using the quasi-likelihood F-test implemented in edgeR (v3.16.5) 46 and genes with P < 0.005 and at least 1.5-fold changes were considered to be differentially expressed. Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper.
Data availability
All the sequencing data reported in this paper are summarized in Supplementary  Table 1 Representative image from at least three independent experiments. b, Coomassie blue staining of purified wild-type or mutant CMD1 proteins. H345 and D347 correspond to the conserved residues of the iron-binding sites based on the sequence alignment of TET homologues; A330 is predicted to be in the active site required for CMD1 enzymatic activity; and D350 might be involved in the 5mC interaction. Representative image from two independent experiments. For source data in a, b, see Supplementary Fig. 1 . c, CMD1 mutants had no or substantially reduced ability to convert 5mC into P1 and P2. Data are representative of two independent experiments. d, P1 and P2 nucleosides accumulate over a period of 2 h upon incubation of the 5mC-DNA substrate with CMD1, as shown by HPLC analysis of nucleosides in DNA samples collected at the indicated time points. Data are representative of two independent experiments. e, Time-course of the relative amounts of 5mC, P1 and P2 during incubation of 5mC-DNA with CMD1. The amount was determined by the peak area of each nucleoside in the HPLC analysis in d. Data are representative of two independent experiments. f, 5mC-DNA, but not C-or 5hmC-containing DNA, serves as a substrate for CMD1. DNA substrates containing C, 5hmC or 5mC were prepared by PCR, incubated with CMD1, and then subjected to nucleoside composition analysis using HPLC. Note that P1 and P2 nucleosides appear in 5mC-DNA only upon incubation with wildtype CMD1. Mut CMD1 is an inactive mutant carrying point mutations (H345Y/D347A). Data are representative of two independent experiments.
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Extended Data Fig. 3 | Deuterium tracing of the methyl group in 5mC-DNA. a, b , Tandem mass spectrometry analysis of the HPLC fractions corresponding to the minor side products generated in the CMD1 reaction and comparison with authentic 5hmC (a) and 5caC (b) standards ( Fig. 1a; see the reaction mechanism proposed in Extended Data Fig. 7c for further discussion of the origins of 5hmC and 5caC). Data are representative of two independent experiments. c, Mass spectrometry detection of 5mC nucleoside in a DNA substrate methylated in vitro with M.SssI using D 3 -labelled S-adenosyl-l-methionine ([methyl-D 3 ]-SAM). The mass of 5mC increases by three units when [methyl-D 3 ]-SAM was used. Data are representative of two independent experiments. d, Identification of P1 and P2 bases using the masses of molecules and fragmentation products from tandem mass spectrometry. P1 and P2 produce identical collision-induced dissociation (CID) fragments, suggesting that they are stereoisomers. The most abundant fragments generated by CID of P1 and P2 are shown. Molecular formulae were deduced from the molecular masses. As all the fragment ions of P1 and P2 that are generated from D 3 -labelled 5mC are 2 D larger than those from unlabelled 5mC, the new modification is likely to occur at the methyl group; the bridging methylene linked to the pyrimidine ring seems unaltered in the CID. P1 and P2 appeared to lose three H 2 O molecules (molecular mass 18.0100) consecutively in CID, indicating the presence of three hydroxyl groups in the P1 and P2 structures. Data are representative of two independent experiments.
Extended Data Fig. 4 | NMR signal assignments support P1 identity as  5-(1-[2,3,4-trihydroxybutyl])-2′-deoxycytidine. a 13 C HMBC spectrum for P2 with assignments. In the same manner as in Extended Data Fig. 4 , the structure of P2 (Fig. 2c) was determined as 5- (1-[2, 3, 4 -trihydroxybutyl])-2′-deoxycytidine using a 1 H NMR spectrum and a series of 2D NMR spectra indicating P2 as a stereoisomer of P1. Unlike P1, there were stronger coupling relationships among H8, H9, H10a and H10b and this showed more complicated splitting of peaks in P2. Therefore, accurate chemical shifts and coupling constants were simulated with NMR-Sim5.4 to achieve the maximum similarity to the experimental data (Extended Data Table 1) . Representative results are shown from two independent experiments.
Extended Data Fig. 6 | Comparison of co-factor requirements of CMD1  and hTET2 . a, The 90-D modification on 5mC does not originate from CMD1 or co-purified small compounds. The CMD1 protein was purified from E. coli grown in M9 medium with 12 C-or 13 C-labelled glucose as the only carbon source. The lack of mass increase in P1 generated with the 13 C-CMD1 preparation suggests that the P1 modification is derived from a reaction component rather than a compound co-purified with the CMD1 enzyme. Data are representative of two independent experiments. b, O 2 is indispensable for CMD1 activity. P1 and P2 were not detectable unless O 2 was bubbled into a reaction mixture that was incubated under an N 2 atmosphere in a glove box. Data are representative of two independent experiments. c, Mass analysis of P1 nucleoside from reactions using 18 O-labelled oxygen or water. The mass of P1 nucleoside remained unaltered compared to that of P1 obtained from the reaction using unlabelled oxygen or water. Data are representative of two independent experiments. d, 2-OG is not required for CMD1. Reactions were performed under indicated conditions and HPLC was used to analyse the nucleosides of DNA products. N-oxalylglycine (N-OG), an analogue of 2-OG, does not inhibit the activity of CMD1. Data are representative of two independent experiments. e, Fe 2+ is indispensable for CMD1 activity. Reactions were performed in the presence of indicated metal ions or EDTA. Data are representative of two independent experiments. f, 2-OG and Fe 2+ , but not vitamin C, are required for the activity of hTET2. Reactions were performed under indicated conditions. N-OG inhibits the activity of hTET2. Data are representative of two independent experiments. g, Analogues of vitamin C do not support CMD1 activity. Data are representative of at least three independent experiments. h, Dehydroascorbic acid (DHA), an oxidized form of vitamin C, supports CMD1 activity only upon its reduction into vitamin C by DTT. The conversion of DHA into vitamin C by DTT was confirmed by mass spectrometry analysis (not shown). Data are representative of at least three independent experiments. i, Heat-inactivated vitamin C (100 °C overnight) does not support CMD1 activity. Data are representative of two independent experiments. Fig. 7 | Characterization of reaction mechanism of CMD1. a, Mass spectrometry analysis of P1 nucleoside from reactions using various 13 C-labelled vitamin-C co-substrates. The use of [ 13 C 6 ]-VC led to a 3-D increase in the mass of P1, whereas no mass change was detected when [1- 13 C]-VC or [3-13 C]-VC was used. This indicated that the glyceryl moiety was from C4-C6 of vitamin C. Data are representative of two independent experiments. b, Mass determination of the most abundant fragment ions generated by CID of P1. Arch arrows denote the relationship of ions featuring the loss of 13 C carbons (top three panels) and loss of 12 C carbons (bottom panel). The masses corresponding to the fragments containing 13 C atoms are indicated in red. These data indicate that 13 C6 of vitamin C ends up in the distal carbon of the side chain of P1 (C10 in Fig. 2c) , and that 13 C from [5-13 C]-VC ends up in C9. Data are representative of two independent experiments. c, Proposed mechanism of CMD1 catalysis. The catalysis starts with the coordination of Fe(ii) to the conserved 2-His-1-carboxylate triad of the enzyme, leaving three sites on the metal that are occupied by water molecules (A). Deprotonated vitamin C displaces two bound water molecules and coordinates to Fe(ii) with its C-1 carbonyl group and C-2 alkoxide (B). Hydrolysis of the bound vitamin C yields the ring-opened intermediate (C), which then tautomerizes to the α-keto form (D). The remaining bound water molecule leaves when 5mC binds to the active site (E). The binding of O 2 to the iron centre generates an Fe(iii)-superoxo intermediate (F). The nucleophilic attack of the distal oxygen onto C-2 of 2-keto-l-gulonate yields an Fe(iv)-peroxo species (G). This species initiates oxidative decarboxylation of vitamin C to produce an Fe(iv)-oxo species, which is coordinated with the C-1 carboxylate of the resulting l-xylonic acid (H). The Fe(iv)-oxo species abstracts a hydrogen atom from 5mC to generate Fe(iii)-hydroxide species and a 5mC radical (I). The C-2 hydroxyl group of the coordinated l-xylonic acid binds to the Fe(iii) centre with loss of a bound water molecule (J). Homolysis of the C2-C3 bond of the coordinated l-xylonic acid and non-stereoselective attack of the 5mC radical lead to the formation of the product nucleobases P1 and P2 and Fe(ii)-bound glyoxylic acid (K). Eventually, glyoxylate dissociates from the iron centre to complete the catalytic cycle. The side reaction that generates 5hmC can be explained by this reaction mechanism; the 5mC radical combines with a hydroxide group linked to Fe(iii) (intermediate I), in a manner similar to reactions catalysed by TET dioxygenases. Notably, however, the generation of trace 5hmC is not dependent on 2-OG (Fig. 3a, Extended Data Fig. 6d) , confirming that a different mechanism is involved. d, GC-MS analysis of the co-product CO 2 from CMD1-catalysed reactions using 13 C-labelled vitamin C. The reactions were carried out in airtight vials and directly subjected to GC-MS analysis. The carbon atom of CO 2 is shown to come from the C1 of vitamin C. Data are representative of two independent experiments. e, Mass spectrometry analysis of the co-product glyoxylic acid upon DNP derivatization. As C4-C6 and C1 of vitamin C were transferred into base P and CO 2 , respectively, the remaining two carbons of vitamin C were converted into glyoxylic acid. This is in close agreement with the mass increases of the glyoxylic acid derivatives when using uniformly labelled 
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